Lv11
40 积分 2025-06-05 加入
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy
5天前
已完结
Detection of Peritoneal Lesions of Hepatocellular Carcinoma Using [
6天前
已关闭
Biodistribution and Radiation Dosimetry of [ 68 Ga]Ga-RAYZ-8009, a Glypican 3–Targeting Compound for Imaging of Hepatocellular Carcinoma
6天前
已完结
PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial
10天前
已完结
PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial
10天前
已完结
Development of Chinese innovative drugs in the USA
2个月前
已完结
The molecular blueprint of targeted radionuclide therapy
2个月前
已完结
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
3个月前
已完结
177Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial
3个月前
已完结
Somatostatin and Somatostatin Receptors
3个月前
已完结
皖公网安备34019202002308
